Bruker AXS Launches Affordable New LynxEye(TM) 1D-Detector for Fast X-Ray Diffraction Measurements in Materials Research and Process Analysis
While even higher detector performance and larger detectors are available for various advanced XRD applications with Bruker AXS' award-winning one-dimensional Vantec(TM)-1, and two-dimensional Vantec(TM)-2000 detectors (2005 R&D 100 Award winner), these inherently are more costly to manufacture.
The LynxEye detector uses affordable, yet high-performance novel compound silicon strip technology, and features a large 14.4 mm by 16 mm active area. Since there is no need for counting gas, cooling water, or liquid nitrogen, the LynxEye is a virtually maintenance-free, compact and robust detector for everyday use. It fits all D4 and D8 series Bruker AXS diffractometers and can be readily exchanged with other detectors. The LynxEye detector will be beneficial for many materials research applications, such as fast qualitative and quantitative phase analysis, crystal structure refinement, micro-strain and crystallite size determination, as well as stress measurements. It will be an attractive choice for many academic and industrial materials research organizations, as well as for advanced process analysis.
Dr. Lutz Bruegemann, XRD Marketing Manager for Bruker AXS, comments: "The new LynxEye complements our X-ray diffraction product line with an affordable yet high performance 1D detector. Even shorter measurement times and real X-ray snapshot movies remain the domain of our larger and ultra-fast VANTEC detectors. We are convinced that our new LynxEye will make faster, high quality X-ray powder diffraction available to a broader customer base."
About Bruker Biosciences (NASDAQ: BRKR)
Bruker BioSciences Corporation, headquartered in Billerica, Massachusetts, is the publicly traded parent company of Bruker AXS Inc. and Bruker Daltonics Inc. Bruker AXS is a leading worldwide developer and provider of advanced X-ray systems which provide solutions for molecular and elemental analysis by X-ray crystallography, X-ray diffraction and X-ray fluorescence. Its systems, which have particular application in the life science, materials science and nanotechnology research fields, provide customers with high-throughput capabilities to determine small molecule and protein structures, or to characterize and determine the composition and properties of advanced and nano-materials. For more information, please visit www.bruker-axs.com.
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's reorganization strategies, integration risks, failure of conditions, technological approaches, product development, market acceptance, cost and pricing of the Company's products, changes in governmental regulations, capital spending and government funding policies, FDA and other regulatory approvals to the extent applicable, competition, the intellectual property of others, patent protection and litigation. These and other factors are identified and described in more detail in our filings with the SEC, including, without limitation, our annual report on Form 10-K for the year ended December 31, 2004, our most recent quarterly reports on Form 10-Q and our current reports on Form 8-K. We disclaim any intent or obligation to update these forward-looking statements.